4C-MAR: Chemical Profile, Research Information, Effects and Safety

4C-MAR, also known as 4′-chloro-4-methylaminorex, is a synthetic compound belonging to the aminorex family. Researchers classify it among newer psychoactive substances (NPS), and scientific information about its pharmacology and long-term safety remains limited. Therefore, 4C-MAR should not be confused with an approved medicine or dietary supplement.

What Is 4C-MAR?

4C-MAR is a chlorinated derivative of methylaminorex. Its systematic chemical name is 4-methyl-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine. Available chemical databases list the molecular formula as C10H11ClN2O and a molecular weight of approximately 210.66 g/mol.

The compound belongs to a group of substances developed as analogues of aminorex-related compounds. Researchers have studied 4C-MAR alongside 4F-MAR and 4B-MAR because these compounds appeared as newer derivatives of the aminorex structure.

4C-MAR Chemical Information

The following information describes the compound from a chemical and research perspective:

• Common name: 4C-MAR
• Alternative name: 4′-Chloro-4-methylaminorex
• Chemical family: Aminorex derivatives
• Molecular formula: C10H11ClN2O
• Molecular weight: 210.66 g/mol
• PubChem CID: 165361753
• IUPAC name: 4-methyl-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine

These identifiers can help researchers distinguish 4C-MAR from other compounds with similar abbreviated names.

How Does 4C-MAR Relate to Other Aminorex Derivatives?

4C-MAR belongs to a broader group of aminorex analogues. Researchers have also identified compounds such as 4F-MAR and 4B-MAR, which contain different halogen substitutions on the aromatic ring. Consequently, these compounds should not be treated as interchangeable simply because they share the “MAR” abbreviation.

Furthermore, the scientific literature notes that these newer derivatives emerged partly because parent aminorex-related compounds are controlled in many jurisdictions. Researchers therefore continue to monitor their chemical characteristics and appearance in drug markets.

Reported Effects and Research Limitations

4C-MAR is generally described in the literature as having stimulant properties. However, researchers have highlighted the limited amount of information available about newer aminorex derivatives. Laboratory identification and chemical characterization do not establish that a substance is safe for human consumption.

Because human clinical research is limited, it is difficult to establish reliable information about long-term effects, interactions, individual sensitivity, or potential toxicity. Therefore, anecdotal reports should not replace controlled scientific evidence.

4C-MAR Safety Considerations

The most important consideration is the lack of comprehensive human safety data. A compound sold under a research-chemical name may also differ in purity, identity, concentration, or contamination. As a result, online descriptions cannot guarantee the composition of a particular sample.

People should also avoid assuming that chemical similarity means similar safety. Small structural changes can alter pharmacological activity and toxicity.

If someone develops severe agitation, chest pain, difficulty breathing, fainting, seizures, dangerously high body temperature, or other serious symptoms after exposure to an unknown stimulant, they should seek emergency medical attention immediately.

Legal and Regulatory Considerations

The legal status of 4C-MAR can vary between countries and may change as authorities identify and regulate new psychoactive substances. Therefore, anyone conducting legitimate research should check the current regulations of the relevant jurisdiction before handling the compound.

Final Thoughts

4C-MAR is a relatively new aminorex derivative that researchers have identified as a stimulant-type novel psychoactive substance. Its chemical identity is better documented than its human safety profile. Consequently, reliable scientific information should be prioritized over vendor descriptions or anecdotal experiences. Current research supports continued analytical and forensic investigation, while substantial questions about pharmacology, toxicity, and long-term effects remain.